Thoracic Surgery Devices Market –- By Product, By Surgery Type, By End Use - Global Forecast, 2025 - 2034

Thoracic Surgery Devices Market Size

The global thoracic surgery devices market size was valued at USD 750.8 million in 2024. The market is anticipated to grow from USD 792.4 million in 2025 to USD 1.37 billion in 2034, growing at a CAGR of 6.3% from 2025 to 2034. Thoracic surgery devices are specialized medical equipment and tools intended for surgical procedures aimed at the organs and structures of the thoracic cavity.
 

The increasing prevalence of lung cancer, chronic obstructive pulmonary disease (COPD), and other thoracic conditions is driving the growth of the market. According to the World Health Organization (WHO), COPD was the fourth leading cause of death globally, accounting for 3.5 million fatalities in 2021.
 

Similarly, in 2023, lung cancer remained the leading cause of cancer-related deaths worldwide, with high mortality rates among both men and women (WHO). These conditions often necessitate surgical intervention, particularly in moderate to severe cases. Factors such as rising smoking rates, pollution, and aging populations are contributing to the growing incidence of these diseases, thereby increasing the demand for advanced thoracic surgical instruments and devices to improve treatment outcomes.
 

The adoption of minimally invasive thoracic surgical techniques, such as video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS), is significantly influencing the market. These techniques offer advantages such as shorter hospital stays, reduced postoperative pain, and fewer complications. Consequently, there is a rising demand for precise, ergonomic, and technologically advanced surgical tools, including digital staplers and robotic systems, to enhance surgical accuracy and efficiency.
 

The shift toward outpatient care has accelerated the growth of ambulatory surgical centers (ASCs) as cost-effective alternatives to hospitals. ASCs are increasingly performing thoracic procedures, particularly those suited for minimally invasive approaches. This trend is driving the demand for compact, user-friendly surgical devices that align with the workflow and spatial constraints of outpatient settings. Manufacturers are focusing on developing instruments that balance performance and cost while ensuring quick turnaround times to meet the operational needs of these facilities.
 

Thoracic Surgery Devices Market Trends

• Robot-based thoracic surgeries are rapidly expanding due to their unique properties of precision and flexibility, coupled with clinical improvement. Robot systems enable surgeons to perform complex procedures through smaller incisions, higher accuracy, and with reduced trauma and recovery time.
   
• Globally, hospitals are purchasing instruments, software, and training focused on compatibility with robotic systems, with da Vinci systems (offered by Intuitive Surgical) gaining traction. This encourages the manufacturing of integrated thoracic surgical devices such as surgical staplers and scissors with robotic systems which fuels the growth of the market and is promoting new levels of surgical efficiency.
   
• AI is revolutionizing thoracic surgery through preoperative planning, intra-operative guidance, and even post-operative assessment. AI imaging platforms can guide surgeons toward possible incision sites, identify anomalies in anatomy, and predict patient outcomes.
   
• Smart digital devices such as smart staplers and forceps with sensors are also being developed for intra-operative feedback. This data movement is yielding refined and real-time surgery, reduced errors, and is compelling device makers to integrate software and analytics into their devices.
   

Thoracic Surgery Devices Market Analysis

In 2021, the global market was valued at USD 642.8 million. The following year, it saw a slight increase to USD 676.2 million, and by 2023, the market further climbed to USD 712.3 million. Based on product type, the global market is segmented into clamps, forceps, graspers, staplers, scissors, spreaders, needle holders, and other products. The staplers segment accounted for the highest market share and was valued at USD 205.9 million in 2024.
 

• Challenging surgical anatomy and procedure exposure is leading to rapid updates in the designs of thoracic staplers, particularly with the introduction of powered, articulating, and digital staplers. The modern staplers provide feedback about tissue compression, include automatic firing of staplers at maximum compression, and provide better ergonomics for simplified correspondence with complex anatomical structures.
   
• All these improvements are necessary in improving the precision of surgeon skill set with the desire to minimize complications such as leaks or stapler misfires and to help minimize operative time. The ability to function in conjunction with robotic platforms and imaging further contributes to their increasing usage and advances the market growth consistently.
   
• Additionally, due to the increased shift of thoracic surgeons toward minimally invasive approaches such as video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS), specialized surgical staplers are in high demand. These staplers need to be precise and accurate in a tissue closure device that causes less trauma and bleeding in the limited and hard-to-reach areas of the thoracic cavity.
   
• In an operating room, staplers facilitate lung resections and vessel sealing with a better speed and safety profile than traditional sutures. The expanding application of surgical staplers in thoracic surgery to improve the outcomes of surgical procedures and reduce the time to perform them are helping the market grow rapidly.

Based on surgery type, the global thoracic surgery devices market is categorized into lobectomy, wedge resection, pneumonectomy, and other surgery types. The lobectomy segment dominated the market with 44.2% market share in 2024.
 

• Lobectomy has long been known as the gold standard and surgical treatment for early-stage non-small cell lung cancer, which represents about 85% of lung cancer cases. As diagnostic tools and screening interventions have become more effective, an increasing number of patients are getting diagnosed at surgical stages, particularly those at higher risk, such as smokers and the elderly.
   
• Thus, the growth in treatable cases is driving demand for thoracic devices designed to assist lobectomy, including advanced staplers, vessel sealers, and energy-based dissection devices, which facilitate the safe and effective removal of a lung lobe.
   
• The recent increase in minimally invasive approaches to lobectomy, most notably with video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS), is also accelerating the demand for lobectomy devices and techniques.
   
• This is predicated on the fact that minimally invasive approaches have improved postoperative outcomes when compared to open thoracotomy, meaning that there is an increase in demand for instruments designed for use through small incisions. The evolution of technology in the field of minimally invasive lobectomy continues to create opportunity for the design and uptake of lobectomy-specific devices.
   

Based on end use, the global thoracic surgery devices market is classified into hospitals, ambulatory surgical centers, and other end users. In 2024, the hospitals segment held the highest market share of 65.2% and is expected to showcase significant growth over the analysis period.
 

• Hospitals and special clinics are managing a growth in patients being admitted for thoracic conditions like lung cancer, trauma, and pulmonary infections. These facilities are the apex for complex thoracic surgery, such as lobectomies, wedge resections, and pneumonectomies, and the increasingly robust patient flow is driving demand for safe, effective, and successful surgical devices.
   
• Additionally, as hospital system expansion develops in thoracic surgical programs, more safe and effective instruments are invested in like powered staplers, energy devices, and endoscopic devices.
   
• Modern hospitals continue to construct hybrid operating rooms including modern imaging, robotic platforms and real-time navigation tools. These integrated environments of surgical practice require thoracic surgery devices capable of seamlessly integrating with high-tech systems and workflows.
   
• These hospitals and larger clinics are prioritizing multi-functional instruments that streamline workflows and precision in surgery. As capital budgets surface, and infrastructure improves especially in tertiary care or academic hospitals, high end thoracic devices capital investment becomes strategic for improving services and facilitating productivity.

The North America thoracic surgery devices market dominated the global market in 2024, valuing at USD 335.6 million. The market dominance is attributed to the high volume of thoracic surgical procedures performed in U.S. and Canada, and widespread availability of advanced healthcare infrastructure.
 

The U.S. market was valued at USD 260.3 million and USD 273.5 million in 2021 and 2022, respectively. The market size reached USD 302.8 million in 2024, growing from USD 287.7 million in 2023.
 

• Lung cancer remains a leading cause of cancer-related deaths in the U.S., with a significant number of individuals with non-small cell lung cancer requiring surgical resection of their tumor. As per American Cancer Society, about 226,650 new cases of lung cancer are expected to be diagnosed in 2025 in the U.S.
   
• Moreover, chronic obstructive pulmonary disease (COPD) is another condition affecting millions of American adults. Like lung cancer, COPD is often managed surgically only in instances of advanced disease. As per the Centers for Disease Control and Prevention, about 16 million individuals were affected with COPD in the U.S. in 2024.
   
• Collectively, lung cancer and COPD burden continues to drive the need for surgical treatment, maintaining a constant and fluid demand for thoracic surgery procedures within hospitals and cancer centers in the US. As a result, thoracic surgery devices including staplers, vessel sealers, and thoracoscopes are finding increasing demand across healthcare settings performing thoracic surgery procedures.
   
• Further, hospitals in the U.S. are readily adopting surgical platforms such as the da Vinci robotic system and video-assisted thoracic surgery (VATS) equipment, to improve and maintain high-quality clinical outcomes, while seeking to minimize or eliminate outpatient complications if possible.
   
• As a result, most hospital systems are allowing surgeons to quickly adopt high-tech, advanced, and minimally invasive thoracic surgery instruments including articulated staplers, robotic-compatible energy devices, and artificial intelligence guided imaging systems, which push continuous growth of the market in the U.S.
   

Europe thoracic surgery devices market accounted for USD 189.2 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Lung cancer is a prevalent form of cancer in Europe, particularly in Hungary, France, and the UK. In 2021, lung cancer represented 4.3% of all deaths in the European Union and accounted for approximately 19.8% of all cancer-related fatalities within the region. As a result, alongside an aging population across the EU, the burden of thoracic diseases presents challenges leading to increased demands for surgical procedures including lobectomies and biopsies.
   
• It is expected that an increasing elderly population is further expected to drive the demand for more advanced thoracic surgical devices across both public and private healthcare systems as older patients often need more effective and accurate techniques that minimize risk via minimally invasive surgery.
   
• European healthcare systems are also more willing to utilize video-assisted thoracic surgery (VATS) and robot-assisted thoracic surgery (RATS), which are providing more optimal clinical outcomes leading to shorter duration of hospitalization. Hospitals throughout Germany, the Netherlands, and Scandinavia are transitioning to increasingly minimally invasive solutions which are fully supported by significant government funding and binding clinical guidelines.
   
• These changes are propelling the demand for specialized thoracic instruments including digital staplers, articulating forceps, and more advanced surgical tools that include imaging used in their systems, all specifically designed to contribute to a procedures approach which is less invasive to open thoracic surgery.
   

Germany thoracic surgery devices market is anticipated to witness considerable growth over the analysis period.
 

• Germany has one of the most advanced healthcare systems in Europe, with a well-connected network of university hospitals and specialized thoracic oncology centers such as Helios Cancer Center, and German Cancer Research Center.
   
• Further, as per the 2022 study published by Journal of Thoracic Oncology, about 64 lung cancer centers across 79 institutions were certified in Germany. These hospitals perform an immense number of procedures each year, including lobectomies, pneumonectomies, and resections of mediastinal tumors.
   
• The volume of cases drives demand for advanced thoracic surgical devices, given the number of advanced surgical procedures being performed, including staplers, energy devices and endoscopic instruments built with the complexity and precision required during such cases.
   
• Germany's healthcare system has a unique setup of compulsory public health insurance and strong reimbursement systems, such as the DRG (Diagnosis-Related Groups) system, which pays for all, or a portion of the thoracic surgeries performed, and the devices utilized.
   

The Asia Pacific thoracic surgery devices market is anticipated to grow at the highest CAGR of 7% during the analysis timeframe.
 

• The incidence of lung cancer and chronic respiratory diseases in the APAC region, particularly in China, India, and Southeast Asia, has considerably increased in relation to the high smoking rates, urban air pollution, and the aging population. As per the Government of India, nearly one million people die due to tobacco use in India, resulting from throat and lung conditions.
   
• These lung conditions often require thoracic surgical treatment, such as lobectomies, biopsies, and tumor resections. As early-stage diagnoses become more prevalent, there is a growing increase in the volume of thoracic surgical procedures and associated devices needed, particularly in major public hospitals and cancer treatment centers in urban areas.
   
• Several APAC countries are heavily investing in creating additional hospitals, surgical spaces, and upgrading medical technologies as part of their national healthcare reform universal coverage program. Foreign direct investment (FDI) in the healthcare sector across the Asia-Pacific (APAC) region has been increasing, as reported by the Economic and Social Commission for Asia and the Pacific. The U.S. remains the largest investor in the region, followed by Switzerland, Japan, Germany, and France.
   
• Countries such as China, India, Vietnam and Indonesia are building regional medical centers to support more complex surgical procedures, including robotic thoracic surgeries. Such initiatives are generating an enormous demand for advanced thoracic surgical instruments such as retractors, forceps, powered surgical staplers, and video-assisted thoracoscopic systems.
   

China thoracic surgery devices market is predicted to grow significantly over the forecast period.
 

• China contributes to the world's largest population of smokers, which together with high air pollution leads to an extremely high incidence of lung cancer and chronic pulmonary diseases.
   
• As per the World Cancer Research Fund, China reported 1.06 million incidence of lung cancer in 2022, which was highest in the world. Given that lung cancer is frequently diagnosed at stages needing surgical intervention, the need for thoracic surgeries including lobectomies and pneumonectomy is increasing significantly.
   
• This surge in demand has contributed to the overall epidemiological burden of lung cancer and is a main driver for an increase in demand of thoracic surgical devices such as staplers, electrosurgical, and endoscopic devices.
   
• The Chinese government is encouraging the development of existing and new tertiary care hospitals and cancers centers through "Healthy China 2030." Tertiary care hospitals have been upgraded with new operating rooms with the capacity for complex thoracic surgeries.
   
• Since surgical capacity is expanding, there is increased need for a breadth of thoracic surgical instruments meant for higher volume, minimally invasive approaches. Public hospitals are ensuring value-based care through adopting advanced thoracic surgical instruments such as powered surgical staplers and scissors, which is further boosting the market growth in China.
   

Brazil is experiencing significant growth in the Latin America thoracic surgery devices market due to the increasing demand for advanced thoracic surgery devices in healthcare.
 

• Brazil has one of the highest rates of lung cancer and tuberculosis in Latin America, both of which often lead to thoracic complications requiring surgical intervention. As per the World Cancer Research Fund, about 44,213 incidence of lung cancer were recorded in Brazil in 2022.
   
• Also, factors such as late diagnosis and chronic pulmonary infections have further driven the demand for procedures like lung resections, biopsies, and thoracic drainage. This has increased the adoption of thoracic surgery devices, including staplers, retractors, and pleural drainage systems, across both public and private hospitals.
   
• While Brazil's public health system (SUS) offers comprehensive healthcare services, private healthcare providers are rapidly expanding by establishing diagnostic and surgical centers. Investments in new operating rooms, robotic surgery platforms, and minimally invasive surgical instruments are being made to cater to high-income patients.
   
• In line with the growing demand for thoracic surgery devices, major urban centers such as São Paulo and Rio de Janeiro are upgrading their surgical offerings. These upgrades include high-performance devices designed for Video-Assisted Thoracic Surgery (VATS) and robotic-assisted thoracic procedures, which is contributing to the growing demand for advanced thoracic surgery devices in Brazil.
   

Saudi Arabia is poised to witness substantial growth in the Middle East and Africa thoracic surgery devices market during the forecast period.
 

• Saudi Arabia is witnessing a rising number of lung cancer patients due to the country's high smoking rates; as well as the high amount of road traffic accidents which usually result in thoracic trauma that often requires surgery.
   
• As per Global Action to End Smoking, a non-profit organization, in 2022, approximately 17.8% of Saudi Arabia's population reported tobacco usage. Such factors are contributing to an increasing demand for thoracic surgical procedures, further increasing the market use for thoracic surgical devices for either emergency or planned surgical procedures.
   
• Saudi Arabia is undergoing significant healthcare reforms under its Vision 2030 initiative. These reforms include the development of additional hospitals and specialized surgical facilities, alongside substantial investments by the Ministry of Health and other government entities in advanced medical and surgical devices to modernize and enhance healthcare infrastructure.
   
• These advancements have expanded options for patients and surgical teams, enabling the adoption of innovative surgical techniques such as video-assisted thoracic surgery (VATS), robotic-assisted procedures, and the use of advanced surgical tools, including hybrid operating rooms equipped with cutting-edge technology.
   

Thoracic Surgery Devices Market Share

The market is characterized by intense competition among established global players, regional manufacturers, and emerging companies. Leading firms such as Medtronic, Johnson & Johnson, Intuitive Surgical, Karl Storz, and ConMed collectively account for approximately 70% of the global market share.
 

These key players employ strategies like acquisitions, business expansion, and new product launches to maintain their market leadership. Furthermore, numerous local and regional companies are intensifying competition by offering cost-effective solutions. These players are actively pursuing strategies such as mergers, acquisitions, and innovative product developments to broaden their product portfolios and strengthen their market presence.
 

Thoracic Surgery Devices Market Companies

Few of the prominent players operating in the thoracic surgery devices industry include:

• B. Braun
• Biolitec
• Boston Scientific
• Cardinal Health
• ConMed
• Cook Medical
• Fujifilm Holdings
• GE Healthcare
• Intuitive Surgical
• Johnson & Johnson
• Karl Storz
• Medela
• Medtronic
• MicroPort
• Olympus
   
• Medtronic is the one of the key player in market with its advanced electrosurgical and stapling technologies, such as the Signia Stapling System, which utilizes real-time feedback and adaptive firing technology for accuracy regarding lung resections. Their Tri-Staple Reloads minimize air leaks, a vital consideration in lobectomies, and their ENERGY platform provides better vessel sealing in complex thoracic cases.
   
• Johnson & Johnson’s subsidiary Ethicon offers ECHELON powered stapling portfolio incorporating gripping surface technology for reliable firing even in thick lung tissue. In addition to this, HARMONIC ultrasonic scalpels offered by the company allows for bloodless dissection while the MONARCH robotic bronchoscopy platform serves to enhance early-enhanced lung cancer diagnostics.
   
• Intuitive Surgical provides a unique and differentiated value proposition in the thoracic surgery devices space, offering instruments such as surgical stablers that can be used with its da Vinci Surgical System.
   

Thoracic Surgery Devices Industry News

• In June 2025, Johnson & Johnson announced the launch of its ETHICON 4000 Stapler in the U.S. This advanced surgical stapler is designed to address tissue complexities and enhance staple line integrity, aiming to reduce the risk of surgical leaks and bleeding complications across various medical specialties.
   
• In April 2025, Intuitive Surgical, one of the leading innovator in robotic-assisted surgery, received U.S. FDA approval for its fully wristed SP SureForm 45 stapler. This device is designed for use with the da Vinci SP surgical system in thoracic, colorectal, and urologic procedures, enhancing precision and efficiency in minimally invasive surgeries.
   
• In March 2025, Olympus Corporation, a global medical technology company dedicated to enhancing health, safety, and quality of life, announced the launch of its first AI-powered clinical decision tool through a strategic partnership with software firm Ziosoft. This development marked a significant advancement in Olympus’s technological capabilities, positioning the company to improve its surgical and clinical outcomes and strengthen its competitive presence in the healthcare market.
   
• In July 2024, Johnson & Johnson introduced the ECHELON 3000 Stapler, a digitally enabled surgical device designed to enhance precision and efficiency in procedures. The device features one-hand powered articulation, addressing the specific needs of patients. With a 39% larger jaw aperture and a 27% wider articulation range, the ECHELON 3000 Stapler offers improved access, and the broadest left/right articulation span among leading handheld laparoscopic staplers.
   

The thoracic surgery devices market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Clamps
• Forceps
• Graspers
• Staplers
• Scissors
• Spreaders
• Needle holders
• Other products

Market, By Surgery Type

• Lobectomy
• Wedge resection
• Pneumonectomy
• Other surgery types

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE